Individual Strategies -
Decades of Experience Handling Florida
Personal Injury and Wrongful Death Claims
Dangerous and Defective Drug Lawyers Whittel & Melton
Ozempic is a type 2 diabetes drug that some people use to reduce weight, even though the FDA has only licensed it to treat diabetes. While stomach troubles are one of the medication’s negative effects, some people have encountered severe gastrointestinal problems, including as frequent vomiting that led to ER trips and even tooth loss. Novo Nordisk, the maker the injectable semaglutide Ozempic and Wegovy, is being sued for failing to disclose the grave nature of these adverse effects.
Ozempic is a brand-name type 2 diabetes drug. One of the side effects of this medication—weight loss—has garnered media attention. It is marketed under the generic name semaglutide. Influencers, celebrities, and the like have reportedly been using it off-label to shed excess pounds, according to reports. The firm that makes Ozempic is Novo Nordisk, the largest pharmaceutical company in Denmark that was established in 1923.
Ozempic is administered once a week by injection into the thigh, upper arm, or stomach. To replicate the pancreas’ release of insulin, the semaglutide then binds GLP-1 receptors. The medication also aids in lowering blood sugar levels and the quantity of sugar the liver releases. By delaying the stomach’s release of food, it can aid in the prevention of blood surges.
Semaglutide: What is It?
Semaglutide is a type of type 2 diabetes medication that is marketed under the trade names Ozempic, Rybelsus, and Wegovy.
Ozempic Side Effects
The following are some of Ozempic’s most typical and minor adverse effects:
More severe adverse effects are possible and include:
Type 1 Diabetes vs. Type 2 Diabetes
When the body can no longer effectively regulate blood sugar levels, a chronic health condition known as diabetes develops.
Although it usually first manifests in early childhood, type 1 diabetes is often known as juvenile-onset diabetes since it can affect adults. When a person has type 1 diabetes, their pancreas does not create enough insulin, which the body needs to control blood sugar levels. Due to the lack of a cure and the need for insulin to control blood sugar, this kind of diabetes is often referred to as insulin-dependent diabetes.
The more prevalent kind of diabetes, known as type 2, usually strikes adults. There are two complications with this type of diabetes. The first is insufficient insulin production by the pancreas. The second is that less insulin is taken up by the body’s cells, which results in less sugar being absorbed and ending up in the bloodstream. Insulin resistance is a symptom of pre-diabetes that can be cured at least partly with medication, adjustments to lifestyle, or a combination of both to avoid the development of type 2 diabetes.
Type 2 diabetes is more likely to affect some people than others. Among the potential risk factors for this illness are:
Type 2 diabetes does not have a treatment. To address the symptoms, there are a few therapies and lifestyle adjustments that can be helpful. Diet and exercise, for instance, can lessen the disease’s severity. For people who do not currently have type 2 diabetes, maintaining a balanced diet and level of fitness can also help avoid the disease.
Insulin treatment and diabetes drugs like Ozempic are the main medical options for type 2 diabetes.
Does Ozempic Help People Lose Weight?
Ozempic may reduce appetite, which is why some people have started using it off-label as a medication to help them lose weight. Although the medicine has not been approved by the FDA as a form of weight-loss, a doctor may still prescribe it if they believe it will benefit the patient.
Ozempic can help people lose weight, but it truly works best for people who are obese and for whom diet and exercise alone will not work. Those aiming to shed a few pounds might be best served by non-medical approaches. Physicians are worried that using Ozempic in those carrying less weight can have more severe adverse effects.
Ozempic suppresses the GLP-1 hormone receptors, which can lead to weight loss. As a result, this amplifies the effects of GLP-1, which have the following effects on the body:
The FDA has not authorized Ozempic as a drug for weight loss despite this side effect. Ozempic’s sibling drug, Wegovy, is also manufactured by Novo Nordisk and is authorized for the treatment of obesity.
Even though Ozempic is intended to treat type 2 diabetes and, with a doctor’s consent, aid in weight loss for obese individuals, many well-known and wealthy individuals are using Ozempic to lose weight. While some deny the use, physicians note that Ozempic also induces a side effect known as “Ozempic face,” or the loss of facial fat, which makes it easy to identify who is using it.
Is Wegovy the Same as Ozempic?
Wegovy and Ozempic are somewhat comparable drugs. Like Ozempic, Wegovy is a semaglutide medication but is given at a larger dosage. The FDA has approved Wegovy for the purpose of treating obesity. Conversely, Ozempic is exclusively authorized by the FDA to treat type 2 diabetes. Even for obese people, taking Ozempic for weight loss is regarded as off-label.
Subcutaneous injections of Ozempic and Wegovy are administered to patients. The primary distinction between the two medications is that Wegovy has been approved by the FDA for use in weight loss at a dosage of 2.4 mg per week, while Ozempic is intended for the treatment of type 2 diabetes at doses of 0.5 to 1 mg weekly.
What is Rybelsus?
Rybelsus, also made by Novo Nordisk, is intended to treat type 2 diabetes mellitus, just like Ozempic. However, the patient takes an oral tablet of this medication every day, not an injection.
The most common side effects of Rybelsus include diarrhea, stomach pain, nausea, vomiting, constipation, and a decrease in appetite. However, there are more serious adverse effects of this drug, that may include:
What About the Ozempic Shortage?
Because so many people, regardless of dosage, are using the drug to lose weight, there is a shortage of Ozempic available for those with type 2 diabetes who require it. Individuals who depend on the drug have been forced to go from Ozempic or its higher-dose equivalent, Wegovy, to alternative medications that may not be as successful at controlling their diabetes.
Some people have taken compounded versions of the semaglutide drug because of the Ozempic shortage. Combining chemicals from different drugs is known as compounding. The FDA has advised patients not to take compounded forms of Ozempic since they have not had their safety evaluated. The FDA generally disapproves of compounded formulas. In addition, the FDA has alerted patients about the possibility that semaglutide salts, rather than the active ingredients that give Ozempic its effectiveness, may be present in Ozempic compounds.
Why Are Ozempic Lawsuits Emerging Now?
The company that makes Ozempic, Novo Nordisk, is currently being sued for serious side effects that users say they were not told about. Severe gastrointestinal issues such as gastroenteritis and gastroparesis have been reported as side effects of Ozempic, Wegovy, and Rybelsus use.
The illness known as gastroenteritis is brought on by inflammation and irritation of the intestines and stomach. If it is caused by a bacterial infection, it may also be referred to as the stomach flu.
Gastroenteritis symptoms can include:
Gastroparesis is a stomach ailment as well. It is also known as delayed gastric emptying. When food remains in the stomach for longer than it should, it can cause gastroparesis.
Among the signs and symptoms of gastroparesis are:
Novo Nordisk did issue a warning, citing connections between using Ozempic, Wegovy, and Rybelsus and experiencing nausea and stomach discomfort. The medication’s side effects list includes the two. However, the semaglutide case brought against the company includes allegations that it failed to alert consumers to the serious stomach problems that the drug could cause, such as gastroenteritis and gastroparesis.
Are You Entitled to Money from Novo Nordisk? Call us now at 866-945-9045 or contact us online for a free consultation.
Ozempic Lawsuits for Stomach Paralysis
In August, 2023, the makers of Ozempic and Mounjaro were named in a lawsuit on the grounds that the medications result in gastroparesis, a serious gastrointestinal ailment. The plaintiff alleges she had taken Ozempic, made by Novo Nordisk, to treat her type 2 diabetes, but had her medication switched to Mounjaro, a similar drug manufactured by Eli Lilly. She alleges in her lawsuit that both companies neglected to alert customers to the possibility of gastrointestinal problems like gastroenteritis and gastroparesis. The lawsuit claims she spent time in the ER and suffered tooth loss due to excessive vomiting.
Can I File a Lawsuit After Taking Ozempic, Wegovy, And/or Rybelsus?
Our Dangerous and Defective Drug Lawyers at Whittel & Melton are currently looking into lawsuits on behalf of those who have undergone GLP-1 RA therapies (pills or injections) under the brands Ozempic, Rybelsus, or Wegovy and:
If you have taken Ozempic and have been diagnosed with any of the following conditions, you might have a case against Novo Nordisk:
Whittel & Melton Can Help
First, talk to your doctor about your health to make sure that taking Ozempic, Wegovy, and/or Rybelsus is what caused your gastrointestinal issues. Then, schedule a free consultation by calling us at 866-945-9045 or contact us online 24/7. After assessing your case, we will determine if you have a valid claim for compensation. You will not be obligated to pay us anything until your lawsuit yields a successful outcome.
Call us now at 866-945-9045 or contact us online for a free consultation.